AMATSIGROUP
Desconocido
REFINE: Regulatory Science Framework for Nano bio material based Medical Products and Devices
AMATSIGROUP
participó en un
H2020:
H2020-NMBP-2016-2017
REFINE proposes a Regulatory Science Framework for the risk-benefit assessment of medical products and medical devices that are based on nan...
2017-11-29 - 2022-02-28 | Financiado
2017-11-29 - 2022-02-28 | Financiado
STRONG: European Consortium for the Study of a Topical Treatment of iCRVO to prevent Neovascular Glaucoma
AMATSIGROUP
participó en un
FP7:
Neovascular glaucoma (NVG) is a very aggressive and rare type of glaucoma: yet, it contributes disproportionately to blindness from all eye...
Financiado
Financiado
* No se disponen de datos de la empresa actual.